Convergence of Nanotechnology and Bacteriotherapy for Biomedical Applications.

Adv Sci (Weinh)

Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison (UW-Madison), Madison, WI, 53705, USA.

Published: April 2024

Bacteria have distinctive properties that make them ideal for biomedical applications. They can self-propel, sense their surroundings, and be externally detected. Using bacteria as medical therapeutic agents or delivery platforms opens new possibilities for advanced diagnosis and therapies. Nano-drug delivery platforms have numerous advantages over traditional ones, such as high loading capacity, controlled drug release, and adaptable functionalities. Combining bacteria and nanotechnologies to create therapeutic agents or delivery platforms has gained increasing attention in recent years and shows promise for improved diagnosis and treatment of diseases. In this review, design principles of integrating nanoparticles with bacteria, bacteria-derived nano-sized vesicles, and their applications and future in advanced diagnosis and therapeutics are summarized.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040386PMC
http://dx.doi.org/10.1002/advs.202309295DOI Listing

Publication Analysis

Top Keywords

delivery platforms
12
biomedical applications
8
therapeutic agents
8
agents delivery
8
advanced diagnosis
8
convergence nanotechnology
4
nanotechnology bacteriotherapy
4
bacteriotherapy biomedical
4
bacteria
4
applications bacteria
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!